Skip to main content

Table 1 Baseline Characteristics of VHL-CNS-Hb/VHL-pNET and Control Cohorts

From: Epidemiology and economic burden of Von Hippel-Lindau Disease-associated central nervous system hemangioblastomas and pancreatic neuroendocrine tumors in the United States

 

VHL-CNS-Hb

vs.

Control

 

VHL-pNET

vs.

Control

 

(N = 220)

 

(N = 1,100)

(N = 20)

 

(N = 100)

Demographic characteristics

            

Female, N (%)

136

(61.8%)

 

678

(61.6%)

 

12

(60.0%)

 

60

(60.0%)

 

Age at index date (years), mean ± SD

49.0

± 11.3

 

49.0

± 11.2

 

47.1

± 14.1

 

47.1

± 13.8

 

Geographic region, N (%)

            

Northeast

22

(10.0%)

 

107

(9.7%)

 

< 5

-

 

8

(8.0%)

 

Midwest

51

(23.2%)

 

284

(25.8%)

 

5

(25.0%)

 

19

(19.0%)

 

South

108

(49.1%)

 

479

(43.5%)

 

10

(50.0%)

 

51

(51.0%)

 

West

38

(17.3%)

 

220

(20.0%)

 

< 5

-

 

22

(22.0%)

 

Unknown

< 5

-

 

10

(0.9%)

 

< 5

-

 

< 5

-

 

Health insurance type, N (%)

            

EPO

19

(8.6%)

 

108

(9.8%)

 

< 5

-

 

8

(8.0%)

 

PPO

17

(7.7%)

 

42

(3.8%)

 

< 5

-

 

5

(5.0%)

 

POS

123

(55.9%)

 

723

(65.7%)

 

12

(60.0%)

 

74

(74.0%)

 

HMO

44

(20.0%)

 

184

(16.7%)

 

< 5

-

 

10

(10.0%)

 

Other1

19

(8.6%)

 

42

(3.8%)

 

< 5

-

 

< 5

-

 

Disease characteristics

            

Year of index date, N (%)

            

2018 − 2012

85

(38.6%)

 

425

(38.6%)

 

8

(40.0%)

 

40

(40.0%)

 

2013–2016

75

(34.1%)

 

375

(34.1%)

 

< 5

-

 

10

(10.0%)

 

2017–2020

60

(27.3%)

 

300

(27.3%)

 

10

(50.0%)

 

50

(50.0%)

 

Comorbidities

            

CCI, mean ± SD

2.0

± 2.6

 

0.4

± 1.0

***

2.8

± 3.6

 

0.3

± 0.8

***

Comorbidities, N (%)

            

Hypertension

100

(45.5%)

 

327

(29.7%)

***

11

(55.0%)

 

28

(28.0%)

*

Depression/anxiety

73

(33.2%)

 

181

(16.5%)

***

9

(45.0%)

 

19

(19.0%)

*

Chronic pulmonary disease

54

(24.5%)

 

103

(9.4%)

***

< 5

-

 

12

(12.0%)

 

Diabetes

34

(15.5%)

 

108

(9.8%)

*

7

(35.0%)

 

5

(5.0%)

**

Osteoporosis/fractures

30

(13.6%)

 

59

(5.4%)

***

< 5

-

 

6

(6.0%)

 

Liver disease

37

(16.8%)

 

33

(3.0%)

***

< 5

-

 

< 5

-

*

Cerebrovascular disease

51

(23.2%)

 

27

(2.5%)

***

< 5

-

 

< 5

-

 

Congestive heart failure

8

(3.6%)

 

23

(2.1%)

 

< 5

-

 

< 5

-

 

Peripheral vascular disease

19

(8.6%)

 

22

(2.0%)

***

< 5

-

 

< 5

-

 

Renal disease

24

(10.9%)

 

20

(1.8%)

***

< 5

-

 

< 5

-

 

Cancer

50

(22.7%)

 

43

(3.9%)

***

7

(35.0%)

 

< 5

-

**

Annual HRU during baseline, mean ± SD

            

Inpatient visits

0.7

± 1.7

 

0.1

± 0.6

***

1.5

± 3.7

 

0.1

± 0.5

 

Inpatient days

2.9

± 7.4

 

0.8

± 7.5

***

4.0

± 5.9

 

0.3

± 1.0

*

ED visits

1.8

± 4.7

 

0.6

± 1.8

***

0.5

± 0.8

 

1.0

± 3.7

 

Outpatient visits

15.2

± 10.6

 

7.7

± 8.8

***

20.1

± 11.3

 

7.1

± 8.3

***

Other visits2

1.8

± 2.9

 

0.8

± 2.2

***

2.1

± 3.2

 

0.5

± 1.3

*

Annual healthcare costs during baseline, mean ± SD

            

Total costs

$44,688

± $92,113

 

$9,102

± $40,331

***

$51,768

± $76,003

 

$5,911

± $13,839

**

Medical costs

$38,869

± $87,536

 

$7,371

± $39,206

***

$46,657

± $75,751

 

$3,309

± $6,529

**

Inpatient costs

$21,270

± $75,640

 

$3,435

± $34,478

***

$9,443

± $13,806

 

$916

± $4,409

**

ED costs

$3,600

± $12,781

 

$635

± $2,579

***

$1,244

± $2,191

 

$443

± $1,458

 

Outpatient costs

$13,519

± $36,804

 

$3,122

± $11,500

***

$35,221

± $76,519

 

$1,917

± $3,364

*

Other costs2

$480

± $2,513

 

$178

± $1,685

*

$749

± $1,514

 

$33

± $106

*

Pharmacy costs

$5,819

± $22,709

 

$1,731

± $7,090

**

$5,112

± $9,488

 

$2,602

± $11,823

 
  1. Abbreviations: CCI: Charlson Comorbidity Index; CNS: central nervous system; ED: emergency department; EPO: exclusive provider organization; GEE: generalized estimating equation; Hb: hemangioblastoma; HMO: health maintenance organization; HRU: healthcare resource utilization; ICD: International Classification of Diseases; pNET: pancreatic neuroendocrine tumor; POS: point of service; PPO: preferred provider organization; SD: standard deviation; USD: United States dollars; VHL: von Hippel-Lindau.
  2. Notes:
  3. * denotes P-values < 0.05; ** denotes P-values < 0.01; *** denotes P-values < 0.001
  4. 1. The “other” health insurance category includes the following types of plans: independent practice organizations, lock-ins, pharmacy network plans, unknown, and no coverage
  5. 2. “Other” medical visits/costs include all those not captured by inpatient, ED, or outpatient visits/costs. These claims may reflect home health aids or physician visits among other types of ancillary medical claims
  6. 3. The dashed cells (“-“) are used for variable categories where there are < 5 patients. According to Optum’s data rules, these numbers need to be redacted to ensure patient privacy